Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Annals of Hematology|February 24, 2015
Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogeneticsSatoshi Yamasaki, Goichi Yoshimoto, Ryosuke Ogawa, et al.Experimental Hematology|May 18, 2016
Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosisShinya Daitoku, Katsuto Takenaka, Takuji Yamauchi, et al.Journal of Hematology & Oncology|February 8, 2013
Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)Koji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, et al.European Journal of Haematology|June 29, 2012
A spindle cell variant of diffuse large B-cell lymphoma is characterized by T-cell/myofibrohistio-rich stromal alterations: analysis of 10 cases and a review of the literatureYoshizo Kimura, Fumiko Arakawa, Junichi Kiyasu, et al.Journal of the American Chemical Society|June 23, 2023
Pore-Networked Gels: Permanently Porous Ionic Liquid Gels with Linked Metal-Organic Polyhedra NetworksZaoming Wang, Aydin Ozcan, Gavin A Craig, et al.International Journal of Hematology|January 14, 2005
Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantationHisashi Gondo, Daisuke Himeji, Kenjiro Kamezaki, et al.Blood|March 9, 2006
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in JapanSung-Won Kim, Tetsuya E Tanimoto, Noriyuki Hirabayashi, et al.International Journal of Hematology|January 13, 2010
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study GroupRitsuko Seki, Koichi Ohshima, Koji Nagafuji, et al.Cancer Science|August 7, 2009
Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab eraRitsuko Seki, Koichi Ohshima, Tomoaki Fujisaki, et al.Pageof 6